Patents by Inventor Clothilde Thiriart

Clothilde Thiriart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition
    Patent number: 7144703
    Abstract: Novel vaccine compositions are provided comprising a hepatitis B antigen formulated with aluminium phosphate. The vaccine compositions may additionally contain an inactivated hepatitis A virus, aluminium hydroxide and formol. The combined hepatitis A and B vaccine formulations can, if desired, be administered to human subjects in a 2 dose regimen. Suitable formulations are illustrated.
    Type: Grant
    Filed: July 1, 2004
    Date of Patent: December 5, 2006
    Assignee: SmithKline Beecham Biologicals, s.a.
    Inventors: Claude Artois, Michael J Clark, Stefan Gabriel Jozef Thoelen, Clothilde Thiriart
  • Hepatitis vaccines containing 3-O-deacylated monophoshoryl lipid A
    Patent number: 6893644
    Abstract: A vaccine formulation for the treatment or prophylaxis of hepatitis, especially hepatitis, especially hepatitis B, infections is provided comprising the hepatitis antigen and a suitable carrier such as alum in combination with 3-O-deacylated monophosphoryl lipid. A combination vaccines including the vaccine formulation are also described.
    Type: Grant
    Filed: June 19, 2003
    Date of Patent: May 17, 2005
    Assignee: SmithKline Beecham Biologicals s.a.
    Inventors: Nathalie Marie-Josephe Claude Garcon-Johnson, Pierre Hauser, Clothilde Thiriart, Pierre Voet
  • Novel composition
    Publication number: 20040241193
    Abstract: Novel vaccine compositions are provided comprising a hepatitis B antigen formulated with aluminium phosphate. The vaccine compositions may additionally contain an inactivated hepatitis A virus, aluminium hydroxide and formol. The combined hepatitis A and B vaccine formulations can, if desired, be administered to human subjects in a 2 dose regimen. Suitable formulations are illustrated.
    Type: Application
    Filed: July 1, 2004
    Publication date: December 2, 2004
    Applicant: SmithKline Beecham Biologicals, s.a.
    Inventors: Claude Artois, Michael J. Clark, Stefan Gabriel Jozef Thoelen, Clothilde Thiriart
  • Hepatitis vaccines containing 3-O-deacylated monophoshoryl lipid A
    Publication number: 20030211120
    Abstract: A vaccine formulation for the treatment or prophylaxis of hepatitis, especially hepatitis B, infections is provided comprising the hepatitis antigen and a suitable carrier such as alum in combination with 3-O-deacylated monophosphoryl lipid A. Combination vaccines including the vaccine formulation are also described.
    Type: Application
    Filed: June 19, 2003
    Publication date: November 13, 2003
    Applicant: SmithKline Beecham Biologicals S.A.
    Inventors: Nathalie Marie-Joseph Claude Garcon-Johnson, Pierre Hauser, Clothilde Thiriart, Pierre Voet
  • Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
    Patent number: 6620414
    Abstract: A vaccine formulation for the treatment or prophylaxis of hepatitis, especially hepatitis B, infections is provided comprising the hepatitis antigen and a suitable carrier such as alum in combination with 3-O-deacylated monophosphoryl lipid A. Combination vaccines including the vaccine formulation are also described.
    Type: Grant
    Filed: August 21, 2001
    Date of Patent: September 16, 2003
    Assignee: SmithKline Beecham Biologicals (s.a.)
    Inventors: Nathalie Marie-Josephe Claude Garcon-Johnson, Pierre Hauser, Clothilde Thiriart, Pierre Voet
  • Novel composition
    Publication number: 20030049268
    Abstract: Novel vaccine compositions are provided comprising a hepatitis B antigen formulated with aluminium phosphate. The vaccine compositions may additionally contain an inactivated hepatitis A virus, aluminium hydroxide and formol. The combined hepatitis A and B vaccine formulations can, if desired, be administered to human subjects in a 2 dose regimen. Suitable formulations are illustrated.
    Type: Application
    Filed: August 20, 2002
    Publication date: March 13, 2003
    Applicant: SmithKline Beecham Biologicals s.a.
    Inventors: Claude Artois, Michael J. Clark, Stefan Gabriel Jozef Thoelen, Clothilde Thiriart
  • Epatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
    Publication number: 20020028209
    Abstract: A vaccine formulation for the treatment or prophylaxis of hepatitis, especially hepatitis B, infections is provided comprising the hepatitis antigen and a suitable carrier such as alum in combination with 3-O-deacylated monophosphoryl lipid A. Combination vaccines including the vaccine formulation are also described.
    Type: Application
    Filed: August 21, 2001
    Publication date: March 7, 2002
    Applicant: SmithKline Beecham Biologicals sa
    Inventors: Nathalie Marie-Josephe Claude Garcon-Johnson, Pierre Hauser, Clothilde Thiriart, Pierre Voet